You should read your "amazing article", repo. And then do the math to assess the
relative risk.
All VITT patients had received a single dose of the ChAdOx1 nCoV-19 vaccine (AstraZeneca COVID-19 Vaccine, AstraZeneca; COVIDSHIELD, Verity Pharmaceuticals and Serum Institute of India
So don't get that vaccine if you're worried. But the article stipulates that VITT is a rare occurrence. Published estimates of the risk of VITT currently range from 1 case per 26,500 to 1 case per 127,300 first doses of AstraZeneca/COVISHIELD administered. The risk of VITT in Canada has been estimated to be approximately 1 per 55,000 first doses.
Compare the worst case scenario (1:26,500) to the risk of death from COVID: about 1.9% in the US, now down near 1% - and the wise choice becomes clear even if AstraZeneca is your only choice.
Which it's not, since it's not even available in the United States. Further, there have been no confirmed cases of VITT with mRNA-based COVID-19 vaccines (e.g., Pfizer and Moderna). But anti-vaxers aren't exactly rational sorts, generally speaking.
Your overall chance of having already died of COVID in the US is already around 1.8:1000* so ...
... thanks for the scaremongering, excuse-providing effort. And for doing your part to keep the new variants coming.
*W-o-M shows 1882 US deaths per million population, and that is widely considered a drastic undercount. VITT cases are treatable with nonheparin antithrombotic agents, rendering the risk of fatality even lower than the odds I provided above.